KERALA AYURVEDA
Back to Balance Sheet
|
KERALA AYURVEDA Last 5 Year Total Non-Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Non-Current Liabilities | ₹23 Cr | ₹65 Cr | ₹55 Cr | ₹42 Cr | ₹67 Cr |
What is the latest Total Non-Current Liabilities ratio of KERALA AYURVEDA ?
| Year | Total Non-Current Liabilities |
|---|---|
| Mar2025 | ₹23 Cr |
| Mar2024 | ₹65 Cr |
| Mar2023 | ₹55 Cr |
| Mar2022 | ₹42 Cr |
| Mar2021 | ₹67 Cr |
How is Total Non-Current Liabilities of KERALA AYURVEDA Trending?
| Years | Total Non-Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹23 Cr | -64.52 | |
| Mar2024 | ₹65 Cr | 19.29 | |
| Mar2023 | ₹55 Cr | 30.65 | |
| Mar2022 | ₹42 Cr | -37.36 | |
| Mar2021 | ₹67 Cr | - | |
Compare Total Non-Current Liabilities of peers of KERALA AYURVEDA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| KERALA AYURVEDA | ₹217.2 Cr | 0.4% | -9.5% | -69.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹463,815.0 Cr | 0.5% | 6.2% | 17.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹192,678.0 Cr | 4.7% | 9% | 7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹161,323.0 Cr | -3.7% | 7.2% | 49.8% | Stock Analytics | |
| CIPLA | ₹114,585.0 Cr | -0.6% | 5% | -3.2% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹101,067.0 Cr | -1.9% | -4.6% | -2.8% | Stock Analytics | |
KERALA AYURVEDA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| KERALA AYURVEDA | 0.4% |
-9.5% |
-69.9% |
| SENSEX | 0.8% |
1.8% |
-6.5% |
You may also like the below Video Courses